Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
Public ClinicalTrials.gov record NCT00000437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Nalmefene in Nicotine and Alcohol Dependence
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence.
Study identification
- NCT ID
- NCT00000437
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Naltrexone Tablet and Nicotine Patch Drug
- Naltrexone Tablet and Placebo Patch Drug
- Placebo Tablet and Nicotine Patch Drug
- Placebo Tablet and Placebo Patch Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 25, 1997
- Primary completion
- Sep 14, 2005
- Completion
- Sep 14, 2005
- Last update posted
- Apr 19, 2017
1997 – 2005
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Department of Psychiatry, University of Miami School of Medicine | Miami | Florida | 33136 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Alcoholism trials
Other public records listing Alcoholism. Sorted by last update posted; newest first. Not a recommendation.
- NCT05747703: Telehealth Treatment for Alcohol Use Disorder Active, not recruiting
- NCT05414240: Ibudilast for Treating Alcohol Use Disorder Active, not recruiting
- NCT06676059: SMART-r: Substance Monitoring and Active Relapse Tracking Repository Recruiting
- NCT02108080: Characterization Imaging Instruments in Alcoholics and Non-Alcoholics Recruiting
- NCT05473598: Stand Down-Think Before You Drink: An RCT of a Mobile App for Hazardous Drinking With Peer Phone Support Active, not recruiting
- NCT02108054: Behavioral and Functional Task Development, Implementation, and Testing Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00000437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2017 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00000437 live on ClinicalTrials.gov.